Home Avulux Eyenavision And Avulux Introduce Chemistrie Avulux Clips For People Living With Migraine...

Eyenavision And Avulux Introduce Chemistrie Avulux Clips For People Living With Migraine And Light Sensitivity

Partnership between Eyenavision and Avulux offers elevated patient care and accelerated practice growth opportunities for eyecare providers

chemistrie logo
All photos courtesy of Avulux

Eyenavision and Avulux launched Chemistrie Avulux, an innovative new on-demand eyeglass clip option for people living with migraine and light sensitivity. The product combines patented, clinically proven Avulux Migraine & Light Sensitivity Lenses with the Chemistrie Lens Layering System, the patented clip-on system that attaches through the use of magnets embedded in the lenses.

“We are excited to partner with Avulux to introduce Chemistrie Avulux,” said Joe Zewe, President and Chief Executive Officer of Eyenavision. “Through the combination of our unique products, eyecare providers can now offer a seamless, on-demand solution for patients who suffer from migraine and light sensitivity. This collaboration underscores Eyenavision’s commitment to expanding patient access to lifestyle-enhancing products through our versatile and customizable Chemistrie system.”

CONVENIENCE

In addition to being a convenient option for people experiencing migraine and light sensitivity, the new Chemistrie Avulux lens also offers all the light filtration properties that Avulux is known for: blocking up to 97 percent of harmful blue, amber and red lightwaves linked to triggering or worsening migraine attacks, while letting in soothing green light.

Available now through Eyenavision’s Chemistrie Certified Lab partners, Chemistrie Avulux will help more eyecare providers (ECPs) expand their scope of practice and offer premium care to patients experiencing migraine.

Migraine, a complex genetic neurological disorder that often includes symptoms such as severe headaches, nausea, sensitivity to light, and visual disturbances, affects nearly 48 million Americans – or as many as one in every five patients in an ECP’s practice. For many of these patients, migraine is triggered or worsened by light. “ECPs can play a key role in caring for patients with migraine and light sensitivity,” said Dr. Charles Posternack, Chief Executive Officer of Avulux. “We are thrilled to partner with Eyenavision to help ECPs expand their scope of practice and support even more patients with the innovative new Chemistrie Avulux clips.”

Learn more about Eyenavision.

Learn more about Avulux.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

- Advertisment -

Most Popular

Topcon MYAH® Now Integrates with WAVE Lens Designer Software

WAVE Eye Care announced at the Global Specialty Lens Symposium (GSLS) in Las Vegas a new integration between Topcon MYAH and WAVE Lens Designer Software, enabling eye...

Technology to Grow a Practice Without Working Weekends

Robert Phyfer, OD, says that strategic investments in practice technology helped his clinic grow from roughly $1.6 million to nearly $3 million in annual...

Increasing Efficiency of Eye Health Testing Protocols

Michael Cymbor, OD, FAAO, says that adopting advanced imaging technology transformed his practice’s workflow and patient care. When his team integrated the Optovue Solix...

Applications Open for Dr. Stephanie Kirschbaum Living in Purpose Program

VSP Vision™ announced the launch of the inaugural Dr. Stephanie Kirschbaum Living in Purpose Program, a new initiative designed to empower doctors to make...